Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Romain Casey

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Frontiers in Immunology|January 23, 2025
Blood immunophenotyping of multiple sclerosis patients at diagnosis identifies a classical monocyte subset associated to disease evolutionStéphane Rodriguez, Laura Couloume, Juliette Ferrant, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 14, 2019
Neuraxial analgesia is not associated with an increased risk of post-partum relapses in MSCaroline Lavie, Fabien Rollot, Françoise Durand-Dubief, et al.
JAMA Neurology|February 12, 2024
Highly Effective Therapies as First-Line Treatment for Pediatric-Onset Multiple SclerosisNail Benallegue, Fabien Rollot, Sandrine Wiertlewski, et al.
European Radiology|April 4, 2025
Evaluation of a deep learning segmentation tool to help detect spinal cord lesions from combined T2 and STIR acquisitions in people with multiple sclerosisBaptiste Lodé, Burhan Rashid Hussein, Cédric Meurée, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 2, 2026
A predictive tool for early treatment escalation after initiation of moderate-efficacy therapy in pediatric-onset multiple sclerosisNail Benallegue, Fabien Rollot, Pietro Iaffaldano, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 11, 2025
Assessing the Risk of Relapse After In Vitro Fertilization in Women With Multiple SclerosisMarie Mainguy, Romain Casey, Sandra Vukusic, et al.
Brain : a Journal of Neurology|June 30, 2026
Blood cytotoxic natural killer-like CD8 + CD94+ T cells migrate to the brain and predict multiple sclerosis severityEmilie Dugast, Sita Shah, Isabel Vogel, et al.
Neurology|January 31, 2016
Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational studyLaetitia Barbin, Chloe Rousseau, Natacha Jousset, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 26, 2022
Comparative Effectiveness of Natalizumab Versus Anti-CD20 in Highly Active Relapsing-Remitting Multiple Sclerosis After Fingolimod WithdrawalFabien Rollot, Justine Couturier, Romain Casey, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 18, 2025
Pregnancy and birth outcomes in women with multiple sclerosis: Comparison of the RESPONSE study to the general French populationElisabeth Maillart, Fabien Rollot, Emmanuelle Leray, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Frontiers in Immunology|January 23, 2025
Blood immunophenotyping of multiple sclerosis patients at diagnosis identifies a classical monocyte subset associated to disease evolutionStéphane Rodriguez, Laura Couloume, Juliette Ferrant, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 14, 2019
Neuraxial analgesia is not associated with an increased risk of post-partum relapses in MSCaroline Lavie, Fabien Rollot, Françoise Durand-Dubief, et al.
JAMA Neurology|February 12, 2024
Highly Effective Therapies as First-Line Treatment for Pediatric-Onset Multiple SclerosisNail Benallegue, Fabien Rollot, Sandrine Wiertlewski, et al.
European Radiology|April 4, 2025
Evaluation of a deep learning segmentation tool to help detect spinal cord lesions from combined T2 and STIR acquisitions in people with multiple sclerosisBaptiste Lodé, Burhan Rashid Hussein, Cédric Meurée, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 2, 2026
A predictive tool for early treatment escalation after initiation of moderate-efficacy therapy in pediatric-onset multiple sclerosisNail Benallegue, Fabien Rollot, Pietro Iaffaldano, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 11, 2025
Assessing the Risk of Relapse After In Vitro Fertilization in Women With Multiple SclerosisMarie Mainguy, Romain Casey, Sandra Vukusic, et al.
Brain : a Journal of Neurology|June 30, 2026
Blood cytotoxic natural killer-like CD8 + CD94+ T cells migrate to the brain and predict multiple sclerosis severityEmilie Dugast, Sita Shah, Isabel Vogel, et al.
Neurology|January 31, 2016
Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational studyLaetitia Barbin, Chloe Rousseau, Natacha Jousset, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 26, 2022
Comparative Effectiveness of Natalizumab Versus Anti-CD20 in Highly Active Relapsing-Remitting Multiple Sclerosis After Fingolimod WithdrawalFabien Rollot, Justine Couturier, Romain Casey, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 18, 2025
Pregnancy and birth outcomes in women with multiple sclerosis: Comparison of the RESPONSE study to the general French populationElisabeth Maillart, Fabien Rollot, Emmanuelle Leray, et al.
Pageof 7